AVITA Medical (NASDAQ:RCEL) Rating Reiterated by Cantor Fitzgerald
Cantor Fitzgerald reissued their overweight rating on shares of AVITA Medical (NASDAQ:RCEL – Free Report) in a report issued on Tuesday, Benzinga reports. Cantor Fitzgerald currently has a $26.00 target price on the stock. Other equities analysts have also issued research reports about the stock. Piper Sandler raised their price objective on shares of AVITA […]
South Australia United Kingdom United States Davidd Otoole Piper Sandler Securities Exchange Commission
Source: wkrb13.com